Table 3 Age-dependent seroprevalence of HSV-1 and HSV-2, Vaud-Fribourg, 1992–3, Men
HSV-1 | HSV-2 | ||||||
|---|---|---|---|---|---|---|---|
Age group | n | Rate seropositive (±SE, 95% CI) | Odds Ratio (95%CI) | P value | Rate seropositive (±SE, 95% CI)) | Odds Ratio (95%CI) | P value |
25–34 | 189 | 58.2 ± 3.6% (51.2–65.3) | 0.39 (0.25–0.62) | <0.001 | 10.6 ± 2.2% (6.2–15.0) | 0.53 (0.29–0.96) | 0.037 |
35–44 | 223 | 66.4 ± 3.2% (60.2–72.6) | 0.56 (0.36–0.87) | 0.010 | 18.4 ± 2.6% (13.3–23.5) | 1.01 (0.61–1.67) | 0.978 |
45–54 a | 186 | 78.0 ± 3.0% (72.0–83.9) | 1.00 (--) | -- | 18.3 ± 2.8% (12.7–23.8) | 1.00 (---) | --- |
55–64 | 132 | 78.8 ± 3.6% (71.8–85.8) | 1.05 (0.61–1.81) | 0.860 | 17.4 ± 3.3% (10.9–23.9) | 0.94 (0.52–1.70) | 0.845 |
65–74 | 85 | 78.8 ± 4.5% (70.1–87.6) | 1.05 (0.56–1.97) | 0.873 | 29.4 ± 5.0% (19.7–39.2) | 1.86 (1.02–3.40) | 0.042 |
Total | 815 | 69.9 ± 1.6% (66.8–73.0) | --- | --- | 17.3% ± 1.3% (14.7–19.9) | --- | --- |